Skip to content

Insider · CIK 0001824280

Carson William H.

Reports to the SEC for 3 companies · BRISBANE, CA

Transactions

35

Companies

3

Filings

20

CIK

0001824280

Forms 4 and 5

Insider transactions

35 trades
DateCompanyValue
2026-06-11ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award—
2026-05-11ANNXAnnexon, Inc.P Purchase+$46.2K
2026-04-10ANNXAnnexon, Inc.P Purchase+$49.6K
2026-03-10ANNXAnnexon, Inc.P Purchase+$45.4K
2025-12-30ANNXAnnexon, Inc.P Purchase+$20.7K
2025-12-01ANNXAnnexon, Inc.P Purchase+$18.4K
2025-10-30ANNXAnnexon, Inc.P Purchase+$13K
2025-09-30ANNXAnnexon, Inc.P Purchase+$12.6K
2025-09-02ANNXAnnexon, Inc.P Purchase+$8,600.35
2025-07-30ANNXAnnexon, Inc.P Purchase+$9,999.45
2025-06-30ANNXAnnexon, Inc.P Purchase+$10.1K
2025-06-05ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award—
2024-12-02ANNXAnnexon, Inc.P Purchase+$17.1K
2024-10-01ANNXAnnexon, Inc.P Purchase+$19.1K
2024-09-03ANNXAnnexon, Inc.P Purchase+$17.5K
2024-08-01ANNXAnnexon, Inc.P Purchase+$20K
2024-07-01ANNXAnnexon, Inc.P Purchase+$16K
2024-06-05ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award—
2024-06-03ANNXAnnexon, Inc.P Purchase+$15.5K
2024-05-01ANNXAnnexon, Inc.P Purchase+$15K
2024-04-08ANNXAnnexon, Inc.P Purchase+$19.4K
2023-09-25Decibel Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer—
2023-09-25Decibel Therapeutics, Inc.D Disposition to Issuer—
2023-09-25Decibel Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer—
2023-09-25Decibel Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer—
2023-06-13Decibel Therapeutics, Inc.Stock Option (right to buy)A Award—
2023-06-13Decibel Therapeutics, Inc.A Award—
2023-06-08ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award—
2022-06-17Decibel Therapeutics, Inc.Stock Option (right to buy)A Award—
2022-06-09ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award—
2021-06-02ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award—
2021-06-02Decibel Therapeutics, Inc.Stock Option (right to buy)A Award—
2021-02-05ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award—
2021-01-22Prevail Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer—
2020-09-09Prevail Therapeutics Inc.Stock Option (Right to Buy)A Award—

Recent filings

20

Companies

3

Address

C/O ANNEXON, INC. 1400 SIERRA POINT PKWY, BLDG C, STE 200

BRISBANE, CA, 94005